2013
DOI: 10.1016/j.jconrel.2013.08.300
|View full text |Cite
|
Sign up to set email alerts
|

Systemic tumor-specific gene delivery

Abstract: The objective of a systemically administered cancer gene therapy is to achieve gene expression that is isolated to the tumor tissue. Unfortunately, viral systems have strong affinity for the liver, and delivery from non-viral cationic systems often results in high expression in the lungs. Non-specific delivery to these organs must be overcome if tumors are to be aggressively treated with genes such as IL-12 which activates a tumor immune response, and TNF-alpha which can induce tumor cell apoptosis. Techniques… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

1
43
0

Year Published

2014
2014
2023
2023

Publication Types

Select...
7
2

Relationship

0
9

Authors

Journals

citations
Cited by 51 publications
(44 citation statements)
references
References 69 publications
1
43
0
Order By: Relevance
“…The main techniques of genetic delivery involve the use of genetically modified viruses, non-viral gene transfers and formation of DNA complexes with inorganic salts, polycations, surfactants, or lipids [1,[4][5][6]. Up to now, viral vectors have been the most frequently applied, but they have several potential disadvantages, such as immunogenicity, insertional mutations, and potential pathogenicity [2]. In contrast, non-viral delivery systems are characterized by several benefits including low cost, non-infectivity, absence of immunogenicity, and the possibility of repeated clinical administration [3].…”
Section: Page 4 Of 37mentioning
confidence: 99%
See 1 more Smart Citation
“…The main techniques of genetic delivery involve the use of genetically modified viruses, non-viral gene transfers and formation of DNA complexes with inorganic salts, polycations, surfactants, or lipids [1,[4][5][6]. Up to now, viral vectors have been the most frequently applied, but they have several potential disadvantages, such as immunogenicity, insertional mutations, and potential pathogenicity [2]. In contrast, non-viral delivery systems are characterized by several benefits including low cost, non-infectivity, absence of immunogenicity, and the possibility of repeated clinical administration [3].…”
Section: Page 4 Of 37mentioning
confidence: 99%
“…The main challenges for the delivery of genetic material lie in the poor cellular penetration and targeting delivery without degradation [1][2][3]. For example, a negatively charged DNA biomacromolecule cannot be taken up by cell membranes without the aid of transporters or vectors owing to its unfavourable surface charge and hydrodynamic volume.…”
Section: Page 4 Of 37mentioning
confidence: 99%
“…Viral and non-viral vectors are used for gene delivery. 170,171 Retroviruses and adeno-associated viruses are the most popular viral vectors for gene delivery. These vectors have a natural mechanism to deliver their genetic materials into the host cells.…”
Section: Gene Deliverymentioning
confidence: 99%
“…Recently, various nucleic acids have been developed for medication including pDNA, antisense DNA, small interfering RNA (siRNA), and microRNA [11][12][13][14][15]. The receptor-mediated targeting by glycosylation has been used for therapy with nucleic acids.…”
Section: Introductionmentioning
confidence: 99%